112 related articles for article (PubMed ID: 20605406)
1. Changes in peripheral blood lymphocyte phenotypes distribution in patients with oral cancer/oral leukoplakia in Taiwan.
Lee JJ; Lin CL; Chen TH; Kok SH; Chang MC; Jeng JH
Int J Oral Maxillofac Surg; 2010 Aug; 39(8):806-14. PubMed ID: 20605406
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
[TBL] [Abstract][Full Text] [Related]
3. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance.
Öhman J; Magnusson B; Telemo E; Jontell M; Hasséus B
Scand J Immunol; 2012 Jul; 76(1):39-48. PubMed ID: 22469080
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH
Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542
[TBL] [Abstract][Full Text] [Related]
5. Decrease in mast cells in oral squamous cell carcinoma: possible failure in the migration of these cells.
Oliveira-Neto HH; Leite AF; Costa NL; Alencar RC; Lara VS; Silva TA; Leles CR; Mendonça FE; Batista AC
Oral Oncol; 2007 May; 43(5):484-90. PubMed ID: 16979374
[TBL] [Abstract][Full Text] [Related]
6. Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential.
Szarka K; Tar I; Fehér E; Gáll T; Kis A; Tóth ED; Boda R; Márton I; Gergely L
Oral Microbiol Immunol; 2009 Aug; 24(4):314-8. PubMed ID: 19572894
[TBL] [Abstract][Full Text] [Related]
7. Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese.
Chung YT; Hsieh LL; Chen IH; Liao CT; Liou SH; Chi CW; Ueng YF; Liu TY
Carcinogenesis; 2009 Feb; 30(2):286-94. PubMed ID: 19126640
[TBL] [Abstract][Full Text] [Related]
8. Specific induction of the high-molecular-weight microtubule-associated protein 2 (hmw-MAP2) by betel quid extract in cultured oral keratinocytes: clinical implications in betel quid-associated oral squamous cell carcinoma (OSCC).
Chen JY; Chang YL; Yu YC; Chao CC; Kao HW; Wu CT; Lin WC; Ko JY; Jou YS
Carcinogenesis; 2004 Feb; 25(2):269-76. PubMed ID: 14604896
[TBL] [Abstract][Full Text] [Related]
9. Differences in oral habit and lymphocyte subpopulation affect malignant transformation of patients with oral precancer.
Yeh CY; Lin CL; Chang MC; Chen HM; Kok SH; Chang SH; Kuo YS; Hahn LJ; Chan CP; Lee JJ; Jeng JH
J Formos Med Assoc; 2016 Apr; 115(4):263-8. PubMed ID: 26412231
[TBL] [Abstract][Full Text] [Related]
10. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
[TBL] [Abstract][Full Text] [Related]
11. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus prevalence in oral squamous cell cancer and in potentially malignant oral disorders in an eastern Hungarian population.
Kis A; Fehér E; Gáll T; Tar I; Boda R; Tóth ED; Méhes G; Gergely L; Szarka K
Eur J Oral Sci; 2009 Oct; 117(5):536-40. PubMed ID: 19758249
[TBL] [Abstract][Full Text] [Related]
13. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
[TBL] [Abstract][Full Text] [Related]
15. Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians.
Jiang Y; Jolly PE; Ellis WO; Wang JS; Phillips TD; Williams JH
Int Immunol; 2005 Jun; 17(6):807-14. PubMed ID: 15944194
[TBL] [Abstract][Full Text] [Related]
16. Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV.
Zarife MA; Reis EA; Carmo TM; Lopes GB; Brandão EC; Silva HR; Santana N; Martins-Filho OA; Reis MG
J Med Virol; 2009 Jan; 81(1):49-59. PubMed ID: 19031471
[TBL] [Abstract][Full Text] [Related]
17. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan.
Chung CH; Yang YH; Wang TY; Shieh TY; Warnakulasuriya S
J Oral Pathol Med; 2005 Sep; 34(8):460-6. PubMed ID: 16091112
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotype of peripheral T lymphocytes, NK cells and expression of CD69 activation marker in patients with recurrent spontaneous abortions, during the mid-luteal phase.
Prado-Drayer A; Teppa J; Sánchez P; Camejo MI
Am J Reprod Immunol; 2008 Jul; 60(1):66-74. PubMed ID: 18593439
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma.
Haya-Fernández MC; Bagán JV; Murillo-Cortés J; Poveda-Roda R; Calabuig C
Oral Dis; 2004 Nov; 10(6):346-8. PubMed ID: 15533209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]